The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Current and future burden of breast cancer: Global statistics for 2020 and 2040
Open accessAbstract
BACKGROUND: Breast cancer is the most commonly diagnosed cancer worldwide, and its burden has been rising over the past decades. In this article, we examine and describe the global burden of breast cancer in 2020 and predictions for the year 2040. METHODS: Estimates of new female breast cancer cases and deaths in 2020 were abstracted from the GLOBOCAN database. Age-standardized incidence and mortality rates were calculated per 100,000 females by country, world region, and level of human development. Predicted cases and deaths were computed based on global demographic projections for the year 2040. RESULTS: Over 2.3 million new cases and 685,000 deaths from breast cancer occurred in 2020. Large geographic variation across countries and world regions exists, with incidence rates ranging from <40 per 100,000 females in some Asian and African countries, to over 80 per 100,000 in Australia/New Zealand, Northern America, and parts of Europe. Smaller geographical variation was observed for mortality; however, transitioning countries continue to carry a disproportionate share of breast cancer deaths relative to transitioned countries. By 2040, the burden from breast cancer is predicted to increase to over 3 million new cases and 1 million deaths every year because of population growth and ageing alone. CONCLUSION: Breast cancer is the most common cancer worldwide and continues to have a large impact on the global number of cancer deaths. Global efforts are needed to counteract its growing burden, especially in transitioning countries where incidence is rising rapidly, and mortality rates remain high.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Breast cancer has become the most commonly diagnosed cancer worldwide, surpassing lung cancer [1, 2].”
From Nanosensitizer-assisted sonodynamic therapy for breast cancer (2025) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“In terms of primary prevention, a reduction in excess body weight and alcohol consumption and increasing physical activity and breastfeeding may have an impact in reducing breast cancer incidence.58”
From Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. (2024) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Self-citationCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Self-citationEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Self-citationCancer statistics for the year 2020: An overview
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021) · International Journal of Cancer · doi:10.1002/ijc.33588 · Cited by 6,308
Self-citationAllemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145
Breast cancer statistics, 2019
Desantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Sauer, A. G., Jemal, A., & Siegel, R. L. (2019) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21583 · Cited by 3,222
Global cancer in women: burden and trends.
Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0858 · Cited by 1,245
Breast-Cancer Screening — Viewpoint of the IARC Working Group
Secretan, B., Scoccianti, C., LOOMIS, D. P., Benbrahim‐Tallaa, L., Bouvard, V., Bianchini, F., & Straíf, K. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1504363 · Cited by 966
Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study
Heer, E., Harper, A., Escandor, N., Sung, H., McCormack, V., & Fidler-Benaoudia, M. M. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30215-1 · Cited by 888
Cancer mortality for selected sites in 24 countries
栗原, 登., & 瀬木, 三. (1960) · Medical Entomology and Zoology · Cited by 880
Human Development Report 2020: The Next Frontier - Human Development and the Anthropocene
United Nations Development Programme (2020) · Human Development Report · doi:10.18356/9789210055161 · Cited by 594
Global trends in breast cancer incidence and mortality 1973–1997
Althuis, M. D., Dozier, J. M., Anderson, W. F., Devesa, S. S., & Brinton, L. A. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyh414 · Cited by 564
Glass, A. G., Lacey, J. V., Carreon, J. D., & Hoover, R. N. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm059 · Cited by 439
Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis
Jedy-Agba, E. E., McCormack, V., Adebamowo, C., & dos‐Santos‐Silva, I. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30259-5 · Cited by 428
Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA
Lund, M. J., Trivers, K. F., Porter, P. L., Coates, R. J., Leyland-Jones, B. R., Brawley, O. W., Flagg, E. W., O’Regan, R. M., Gabram, S. G. A., & Eley, J. W. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9926-3 · Cited by 398
Munsell, M. F., Sprague, B. L., Berry, D. A., Chisholm, G. B., & Trentham‐Dietz, A. (2013) · Epidemiologic Reviews · doi:10.1093/epirev/mxt010 · Cited by 384
Cancer Epidemiology and Prevention
(2017) · Oxford University Press eBooks · doi:10.1093/oso/9780190238667.001.0001 · Cited by 365
Cancer incidence in five continents : a technical report
Doll, R., Payne, P. M., & Waterhouse, J. A. H. (1966) · Springer eBooks · Cited by 319
Anderson, B. O., Cazap, E. L., Saghir, N. S. E., Yip, C. H., Khaled, H. M., Otero, I. V., Adebamowo, C., Badwe, R. A., & Harford, J. B. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70031-6 · Cited by 319
Anderson, B. O., Ilbawi, A., Fidarova, E. F., Weiderpass, E., Stevens, L. M., Abdel–Wahab, M., & Mikkelsen, B. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00071-1 · Cited by 296
Joko-Fru, W. Y., Miranda‐Filho, A., Soerjomataram, I., Egue, M., Akele‐Akpo, M., N’Da, G., Assefa, M., Buziba, N. G., Korir, A., Kamaté, B., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32406 · Cited by 283
Self-citationPorter, P. L., El-Bastawissi, A. Y., Mandelson, M. T., Lin, M., Khalid, N., Watney, E., Cousens, L. A., White, D., Taplin, S. H., & White, E. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.23.2020 · Cited by 264
McCormack, V., McKenzie, F., Foerster, M., Zietsman, A., Galukande, M., Adisa, C., Anele, A., Parham, G., Pinder, L. F., Cubasch, H., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30261-8 · Cited by 234
Eijkelboom, A. H., de Munck, L., Peeters, M.-J. T. F. D. V., Broeders, M. J. M., Strobbe, L. J. A., Bos, M. E. M. M., Schmidt, M. K., Páez, C. G., Smidt, M. L., Bessems, M., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01073-7 · Cited by 156
Self-citationUpdate on mammography trends: Comparisons of rates in 2000, 2005, and 2008
Breen, N., Gentleman, J. F., & Schiller, J. S. (2011) · Cancer · doi:10.1002/cncr.25679 · Cited by 155
Joko‐Fru, W. Y., Jedy‐Agba, E., Korir, A., Ogunbiyi, O., Dzamalala, C. P., Chokunonga, E., Wabinga, H., Manraj, S., Finesse, A., Somdyala, N., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33014 · Cited by 143
Dinmohamed, A. G., Cellamare, M., Visser, O. J., de Munck, L., Elferink, M. A. G., Westenend, P. J., Wesseling, J., Broeders, M. J. M., Kuipers, E. J., Merkx, M. A. W., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00984-1 · Cited by 142
Self-citationDuggan, C. R., Dvaladze, A. L., Rositch, A. F., Ginsburg, O., Yip, C. H., Horton, S., Rodríguez, R. C., Eniu, A. E., Mutebi, M. C., Bourque, J., et al. (2020) · Cancer · doi:10.1002/cncr.32891 · Cited by 135
Self-citationBirnbaum, J. K., Duggan, C. R., Anderson, B. O., & Etzioni, R. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30257-2 · Cited by 127
Gathani, T., Clayton, G., MacInnes, E., & Horgan, K. J. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01182-z · Cited by 105
Ngan, T. T., Nguyen, N. T. Q., Minh, H. V., Donnelly, M., & O’Neill, C. (2020) · BMC Cancer · doi:10.1186/s12885-020-07521-w · Cited by 104
Toss, A., Isca, C., Venturelli, M., Nasso, C., Ficarra, G., Bellelli, V., Armocida, C., Barbieri, E., Cortesi, L., Moscetti, L. I., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100055 · Cited by 96
Eijkelboom, A. H., de Munck, L., Lobbes, M. B. I., van Gils, C. H., Wesseling, J., Westenend, P. J., Páez, C. G., Pijnappel, R. M., Verkooijen, H. M., Broeders, M. J. M., et al. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106602 · Cited by 69
Self-citationFilipe, M. D., van Deukeren, D., Kip, M., Doeksen, A., Pronk, A., Verheijen, P. M., Heikens, J. T., Witkamp, A. J., & Richir, M. C. (2020) · Clinical Breast Cancer · doi:10.1016/j.clbc.2020.08.002 · Cited by 68
Anderson, W. F., Rosenberg, P. S., Petito, L. C., Katki, H. A., Ejlertsen, B., Ewertz, M., Rasmussen, B., Jensen, M., & Kroman, N. T. (2013) · International Journal of Cancer · doi:10.1002/ijc.28222 · Cited by 59
Mesa‐Eguiagaray, I., Wild, S. H., Rosenberg, P. S., Bird, S. M., Brewster, D., Hall, P. S., Cameron, D., Morrison, D. S., & Figueroa, J. D. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0938-z · Cited by 54
Cancer Incidence in Five Continents. Cumulative rate and cumulative risk.
Day, N. E. (1992) · PubMed · Cited by 41
Mullooly, M., Murphy, J., Gierach, G. L., Walsh, P. M., Deady, S., Barron, T. I., Sherman, M. E., Rosenberg, P. S., & Anderson, W. F. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.08.031 · Cited by 36
Dvaladze, A. L., Duggan, C. R., & Anderson, B. O. (2020) · Cancer · doi:10.1002/cncr.32942 · Cited by 6
Breast cancer: global quality care
SIMONS, P. J. (2021) · Tijdschrift voor Geneeskunde · doi:10.47671/tvg.77.21.076 · Cited by 3
Cited by
Sorted by citations
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064
Self-citationGlobal patterns and trends in breast cancer incidence and mortality across 185 countries
Kim, J., Harper, A., McCormack, V., Sung, H., Houssami, N., Morgan, E., Mutebi, M. C., Garvey, G., Soerjomataram, I., & Fidler-Benaoudia, M. M. (2025) · Nature Medicine · doi:10.1038/s41591-025-03502-3 · Cited by 1,327
Self-citationAdvancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
Ye, F., Dewanjee, S., Li, Y., Jha, N. K., Chen, Z., Kumar, A., vishakha, V., Behl, T., Jha, S. K., & Tang, H. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01805-y · Cited by 619
Global Disparities of Cancer and Its Projected Burden in 2050
Bizuayehu, H. M., Ahmed, K. Y., Kibret, G. D., Dadi, A. F., Belachew, S. A., Bagade, T., Tegegne, T. K., Venchiarutti, R. L., Kibret, K. T., Habte, A., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.43198 · Cited by 456
Towards targeting the breast cancer immune microenvironment
Harris, M. A., Savas, P. S., Virassamy, B., O’Malley, M. M. R., Kay, J., Mueller, S. N., Mackay, L. K., Salgado, R., & Loi, S. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00714-6 · Cited by 409
Metadata
- Authors
- Arnold, M., Morgan, E., Rumgay, H., Mafra, A., Singh, D., Laversanne, M., Vignat, J., Gralow, J. R., Cardoso, F., Siesling, S., & Soerjomataram, I.
- Affiliations
- Centre international de recherche sur le cancer (FR)
- American Society of Clinical Oncology (US)
- Netherlands Comprehensive Cancer Organisation (NL)
- Corresponding author
- Morgan, Eileen
- ORCID
- Venue
- The Breast
- Publisher
- Elsevier BV
- Published
- 2022-12
- Volume
- 66
- Pages
- 15-23
- ISSN
- 0960-9776 (ISSN-L)
- PMC
- PMC9465273
- OpenAlex
- W4294189863
- Cited by
- 3,411
- References
- 43
- Citations by year
- 2026: 694 · 2025: 1176 · 2024: 997 · 2023: 516 · 2022: 23
- FWCI
- 284.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- The Breast (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- University of Twente Research Information (publishedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Twente Research Information (submittedVersion, cc-by-nc-nd)
- Funders
- Susan G. Komen (CCR19608129)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Keywords
- breast cancer, global burden of disease, incidence, mortality, age-standardized rates, population projections, 2040 projections, regional variation, human development, cancer epidemiology
- MeSH terms
- Australia, Breast Neoplasms, Europe, Female, Forecasting, Humans, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review